sj-tif-1-tam-10.1177_17588359221080298 – Supplemental material for Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

Supplemental material, sj-tif-1-tam-10.1177_17588359221080298 for Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience by Tiago de Castro, Leonie S. Jochheim, Melanie Bathon, Sabrina Welland,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	de Castro, Tiago, Jochheim, Leonie S., Bathon, Melanie, Welland, Sabrina, Scheiner, Bernhard, Shmanko, Kateryna, Roessler, Daniel, Khaled, Najib Ben, Jeschke, Matthias, Ludwig, Johannes M., Marquardt, Jens U., Weinmann, Arndt, Pinter, Matthias, Lange, Christian M., Vogel, Arndt, Saborowski, Anna
Format:	Bild
Sprache:	eng
Schlagworte:	Aged Health Care FOS: Clinical medicine FOS: Health sciences Oncology and Carcinogenesis not elsewhere classified Pharmacology and Pharmaceutical Sciences not elsewhere classified Respiratory Diseases
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Supplemental material, sj-tif-1-tam-10.1177_17588359221080298 for Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience by Tiago de Castro, Leonie S. Jochheim, Melanie Bathon, Sabrina Welland, Bernhard Scheiner, Kateryna Shmanko, Daniel Roessler, Najib Ben Khaled, Matthias Jeschke, Johannes M. Ludwig, Jens U. Marquardt, Arndt Weinmann, Matthias Pinter, Christian M. Lange, Arndt Vogel and Anna Saborowski in Therapeutic Advances in Medical Oncology
DOI:	10.25384/sage.19243142